{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:38:59Z","timestamp":1793763539533,"version":"4.6.1"},"reference-count":148,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.retram.2025.103512","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T02:40:19Z","timestamp":1743475219000},"page":"103512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The vaso-occlusive pain crisis in sickle cell patients: A focus on pathogenesis"],"prefix":"10.1016","volume":"73","author":[{"given":"Fatemeh Javaherforoosh","family":"Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadtaghi","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadamin","family":"Eslami Samarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Nikoubakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Dadgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9757","key":"10.1016\/j.retram.2025.103512_bib0001","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.retram.2025.103512_bib0002","first-page":"1404","article-title":"Evaluation of genes and molecular pathways involved in pathogenesis of Sickle cell anemia: a bioinformatics analysis and Future perspective","volume":"53","author":"Maddah","year":"2024","journal-title":"Iran J Public Health"},{"issue":"24","key":"10.1016\/j.retram.2025.103512_bib0003","first-page":"3892","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.NURSE.0000510745.32219.dd","article-title":"Acute vaso-occlusive crisis in patients with sickle cell disease","volume":"47","author":"Lentz","year":"2017","journal-title":"Nursing2024"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12020-023-03520-6","article-title":"Screening for primary aldosteronism on and off interfering medications","volume":"83","author":"Li","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.retram.2025.103512_bib0006","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2147\/JPR.S185582","article-title":"Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management","author":"Uwaezuoke","year":"2018","journal-title":"J Pain Res"},{"key":"10.1016\/j.retram.2025.103512_bib0007","doi-asserted-by":"crossref","first-page":"0160","DOI":"10.34133\/cbsystems.0160","article-title":"Sensors and devices guided by artificial intelligence for personalized pain medicine","volume":"5","author":"Xing","year":"2024","journal-title":"Cyborg Bionic Syst"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ejh.12460","article-title":"Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease","volume":"95","author":"Ballas","year":"2015","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.retram.2025.103512_bib0009","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0889-8588(05)70396-8","article-title":"Pathophysiology of vaso-occlusion","volume":"10","author":"Ballas","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0010","first-page":"1349","article-title":"Approach to the vaso-occlusive crisis in adults with sickle cell disease","volume":"61","author":"SH","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.retram.2025.103512_bib0011","doi-asserted-by":"crossref","first-page":"0188","DOI":"10.34133\/cbsystems.0188","article-title":"Multi-section magnetic soft robot with multirobot navigation system for vasculature intervention","volume":"5","author":"Li","year":"2024","journal-title":"Cyborg Bionic Syst"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0012","article-title":"Evaluation of the efficiency of indirect blood pressure measurement methods in comparison to intra-arterial reading among Iranian individuals","volume":"14","author":"Emami","year":"2020","journal-title":"Int Cardiovasc Res J"},{"key":"10.1016\/j.retram.2025.103512_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720955000","article-title":"Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease","volume":"11","author":"Osunkwo","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0014","first-page":"29","article-title":"Vitamin D and calcium deficiency and its relationship with cardiac function in patients with beta thalassemia","volume":"31","author":"Ahmadipour","year":"2024","journal-title":"J Kerman Univ Med Sci"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2007.06794.x","article-title":"Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?","volume":"139","author":"Vekilov","year":"2007","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0016","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/s41467-023-40923-5","article-title":"Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling","volume":"14","author":"De Souza","year":"2023","journal-title":"Nat Commun"},{"issue":"26","key":"10.1016\/j.retram.2025.103512_bib0017","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1922004117","article-title":"Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease","volume":"117","author":"Henry","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.retram.2025.103512_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229959","article-title":"Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: a systematic literature review and meta-analysis","volume":"15","author":"Ataga","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0019","first-page":"1535","article-title":"Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease","volume":"109","author":"Kaminski","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2025.103512_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2020.04.012","article-title":"Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives","volume":"224","author":"de Azevedo","year":"2020","journal-title":"Immunol Lett"},{"issue":"22","key":"10.1016\/j.retram.2025.103512_bib0021","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1182\/blood.2022019282","article-title":"Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation","volume":"142","author":"Ivy","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103512_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110525","article-title":"NF-\u03bab pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity","volume":"130","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72338-3","article-title":"Endothelial dysfunction in small arteries and early signs of atherosclerosis in ApoE knockout rats","volume":"10","author":"Berenji Ardestani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.retram.2025.103512_bib0024","article-title":"Synergistic effect of VEGF and SDF-1\u03b1 in endothelial progenitor cells and vascular smooth muscle cells","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.retram.2025.103512_bib0025","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biocel.2006.01.010","article-title":"Sickle cell disease and nitric oxide: a paradigm shift?","volume":"38","author":"Mack","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0026","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.freeradbiomed.2006.08.017","article-title":"Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias","volume":"41","author":"Jeffers","year":"2006","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65188-w","article-title":"An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus","volume":"14","author":"Zaib","year":"2024","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.retram.2025.103512_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184411","article-title":"Vascular endothelial cell biology: an update","volume":"20","author":"Kr\u00fcger-Genge","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.retram.2025.103512_bib0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2024.05.003","article-title":"Endothelial dysfunction in Sickle Cell Disease: strategies for the treatment","volume":"149","author":"Pavan","year":"2024","journal-title":"Nitric Oxide"},{"issue":"6","key":"10.1016\/j.retram.2025.103512_bib0030","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood.V98.6.1955","article-title":"P-selectin mediates the adhesion of sickle erythrocytes to the endothelium","volume":"98","author":"Matsui","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0031","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3324\/haematol.2009.017392","article-title":"Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium","volume":"95","author":"Trinh-Trang-Tan","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0032","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/15353702211005392","article-title":"Sickle cell vaso-occlusion: the dialectic between red cells and white cells","volume":"246","author":"Conran","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0033","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41392-023-01652-9","article-title":"Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduction Targeted therapy"},{"issue":"11","key":"10.1016\/j.retram.2025.103512_bib0034","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1182\/blood.V110.11.2264.2264","article-title":"The adhesion of sickle cell disease neutrophils to endothelial layers, In vitro, is mediated by the Mac-1, LFA-1 and VLA-4 integrins","volume":"110","author":"Canalli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103512_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116849","article-title":"Impacts of oxidative stress and anti-oxidants on the development, pathogenesis, and therapy of sickle cell disease: a comprehensive review","volume":"176","author":"Pavitra","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"Supplement 1","key":"10.1016\/j.retram.2025.103512_bib0036","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood.V130.Suppl_1.767.767","article-title":"Protective role of HO-1 expressing CD16+ patrolling monocytes against hemolysis-induced endothelial damage and vaso-occlusive crisis in sickle cell disease","volume":"130","author":"Liu","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0037","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s12033-023-01010-8","article-title":"Molecular insights into the relationship between platelet activation and endothelial dysfunction: molecular approaches and clinical practice","volume":"66","author":"Kazemi","year":"2024","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.retram.2025.103512_bib0038","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood.V130.Suppl_1.767.767","article-title":"Protective role of HO-1 expressing CD16+ patrolling monocytes against hemolysis-induced endothelial damage and vaso-occlusive crisis in sickle cell disease","volume":"130","author":"Liu","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0039","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2002-11-3483","article-title":"Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow","volume":"101","author":"Lagadec","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0040","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3324\/haematol.2019.239350","article-title":"The molecular basis for the prothrombotic state in sickle cell disease","volume":"105","author":"Shet","year":"2020","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0041","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3324\/haematol.2019.239343","article-title":"Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance","volume":"105","author":"Conran","year":"2020","journal-title":"Haematologica"},{"issue":"34","key":"10.1016\/j.retram.2025.103512_bib0042","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207592119","article-title":"Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease","volume":"119","author":"Shi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0043","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arteriosclerosis Thrombosis Vascular Biol"},{"issue":"20","key":"10.1016\/j.retram.2025.103512_bib0044","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019003543","article-title":"Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease","volume":"135","author":"Sparkenbaugh","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0146-0005(97)80006-7","article-title":"Nitric oxide and platelet function: implications for neonatology","volume":"21","author":"Cheung","year":"1997","journal-title":"Semin Perinatol"},{"issue":"11","key":"10.1016\/j.retram.2025.103512_bib0046","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ajh.26308","article-title":"Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease","volume":"96","author":"Hebbel","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0047","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0048","article-title":"The role of RBC oxidative stress in sickle cell disease: from the molecular basis to pathologic implications","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.retram.2025.103512_bib0049","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.97","article-title":"Perfusion magnetic resonance abnormalities in patients with sickle cell disease","volume":"49","author":"Kirkham","year":"2001","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ehf2.14592","article-title":"Association between white blood cell-to-haemoglobin ratio and 30 day mortality in heart failure in intensive care unit","volume":"11","author":"Ren","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0051","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ajh.24467","article-title":"Dense red blood cell and oxygen desaturation in sickle-cell disease","volume":"91","author":"Di Liberto","year":"2016","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0052","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/15353702211005392","article-title":"Sickle cell vaso-occlusion: the dialectic between red cells and white cells","volume":"246","author":"Conran","year":"2021","journal-title":"Exp Biol Med"},{"issue":"6","key":"10.1016\/j.retram.2025.103512_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.55729\/2000-9666.1411","article-title":"Evaluating the cavitary lung lesions on CT scan of COVID-19 patients: a retrospective study","volume":"14","author":"Moradi","year":"2024","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0054","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ajh.24467","article-title":"Dense red blood cell and oxygen desaturation in sickle-cell disease","volume":"91","author":"Di Liberto","year":"2016","journal-title":"Am J Hematol"},{"issue":"21","key":"10.1016\/j.retram.2025.103512_bib0055","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood.V124.21.2713.2713","article-title":"Desaturation is related to the presence of dense red blood cells in sickle cell patients and is reversed by hydroxyurea","volume":"124","author":"Di Liberto","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0056","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.resp.2007.12.005","article-title":"The oxygen affinity of sickle hemoglobin","volume":"161","author":"Abdu","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"issue":"6","key":"10.1016\/j.retram.2025.103512_bib0057","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00000441-200112000-00007","article-title":"Carboxyhemoglobin levels in patients with sickle-cell anemia: relationship to hemolytic and vasoocclusive severity","volume":"322","author":"Sears","year":"2001","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.retram.2025.103512_bib0058","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3324\/haematol.2020.261586","article-title":"Oxidative stress activates red cell adhesion to laminin in sickle cell disease","volume":"106","author":"Lizarralde-Iragorri","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0059","first-page":"17","article-title":"Hypoxemia in sickle cell disease: significance and management","volume":"15","author":"Caboot","year":"2014","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0060","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1002\/ctm2.402","article-title":"Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A","volume":"11","author":"Zhao","year":"2021","journal-title":"Clin Transl Med"},{"issue":"15","key":"10.1016\/j.retram.2025.103512_bib0061","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMcibr023045","article-title":"Hemoglobin and the paracrine and endocrine functions of nitric oxide","volume":"348","author":"Schechter","year":"2003","journal-title":"New Eng J Med"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0062","article-title":"Crosstalk between Heme Oxygenase-1 and iron metabolism in macrophages: implications for the modulation of","volume":"11","author":"de Oliveira","year":"2022","journal-title":"Inflammation Immun Antioxidants (Basel)"},{"key":"10.1016\/j.retram.2025.103512_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100181","article-title":"Ferroptosis as an emerging target in sickle cell disease","volume":"7","author":"Fortuna","year":"2024","journal-title":"Curr Res Toxicol"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0064","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e32835f55f9","article-title":"New insights into sickle cell disease: a disease of hypoxia","volume":"20","author":"Sun","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12967-021-03074-z","article-title":"Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events","volume":"19","author":"Jang","year":"2021","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0066","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI115041","article-title":"Hypoxia-induced in vivo sickling of transgenic mouse red cells","volume":"87","author":"Rubin","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2025.103512_bib0067","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood-2021-149121","article-title":"Hypoxia impact on red blood cell-mediated microvascular occlusion and adhesion in sickle cell disease and sickle cell trait","volume":"138","author":"Man","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0068","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/14728222.2024.2367640","article-title":"Targeting HIF-1\u03b1 in sickle cell disease and cancer: unraveling therapeutic opportunities and risks","volume":"28","author":"Ubaid","year":"2024","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"10.1016\/j.retram.2025.103512_bib0069","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1074\/jbc.272.9.5375","article-title":"Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia","volume":"272","author":"Lee","year":"1997","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.retram.2025.103512_bib0070","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/1535370216642046","article-title":"Diametric effects of hypoxia on pathophysiology of sickle cell disease in a murine model","volume":"241","author":"Tan","year":"2016","journal-title":"Exp Biol Med"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0071","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1172\/JCI133639","article-title":"The multifaceted role of ischemia\/reperfusion in sickle cell anemia","volume":"130","author":"Hebbel","year":"2020","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.retram.2025.103512_bib0072","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.117.110650","article-title":"Long noncoding RNA LINC00657 acting as a mir-590-3p sponge to facilitate low concentration oxidized low-density lipoprotein\u2013induced angiogenesis","volume":"93","author":"Bao","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.retram.2025.103512_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1059106","article-title":"Allium sativum: a potential natural compound for NAFLD prevention and treatment","volume":"10","author":"Mardi","year":"2023","journal-title":"Front Nutr"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0074","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00043426-199208000-00007","article-title":"Oxygen therapy in sickle cell disease","volume":"14","author":"Zipursky","year":"1992","journal-title":"J Pediatric Hematology\/Oncology"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0075","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0076","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0077","first-page":"17","article-title":"Oxidative profile of patients with sickle cell disease","volume":"7","author":"Antwi-Boasiako","year":"2019","journal-title":"Med Sci"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0078","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.85.1.237","article-title":"Accelerated autoxidation and heme loss due to instability of sickle hemoglobin","volume":"85","author":"Hebbel","year":"1988","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0079","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/ATVBAHA.120.315081","article-title":"Xanthine oxidase drives hemolysis and vascular malfunction in sickle cell disease","volume":"41","author":"Schmidt","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.20991","article-title":"Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients","volume":"83","author":"Mar\u00e7al","year":"2008","journal-title":"Am J Hematol"},{"issue":"26","key":"10.1016\/j.retram.2025.103512_bib0081","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"24","key":"10.1016\/j.retram.2025.103512_bib0082","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2014-03-563874","article-title":"Erythroid DAMPs drive inflammation in SCD","volume":"123","author":"Gladwin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103512_bib0083","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fimmu.2014.00099","article-title":"DAMP-mediated activation of NLRP3-inflammasome in brain sterile inflammation: the fine line between healing and neurodegeneration","volume":"5","author":"Rubartelli","year":"2014","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.retram.2025.103512_bib0084","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3324\/haematol.2013.088021","article-title":"Nucleosomes and neutrophil activation in sickle cell disease painful crisis","volume":"98","author":"Schimmel","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.retram.2025.103512_bib0085","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","article-title":"Ischemia-reperfusion injury in sickle cell disease: from basics to therapeutics","volume":"189","author":"Ansari","year":"2019","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0086","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0087","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/rth2.12463","article-title":"Neutrophil extracellular trap regulators in sickle cell disease: modulation of gene expression of PADI4, neutrophil elastase, and myeloperoxidase during vaso-occlusive crisis","volume":"5","author":"Hounkpe","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0088","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood.V81.10.2492.2492","article-title":"Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event","volume":"81","author":"Kaplanski","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089012","article-title":"Endothelial activation by platelets from sickle cell anemia patients","volume":"9","author":"Proenca-Ferreira","year":"2014","journal-title":"PloS One"},{"issue":"17","key":"10.1016\/j.retram.2025.103512_bib0090","first-page":"3329","article-title":"Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson","volume":"121","author":"Field","year":"2013","journal-title":"Blood, J Am Soc Hematology"},{"issue":"4","key":"10.1016\/j.retram.2025.103512_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2023.104205","article-title":"Complement involvement in sickle cell disease","volume":"52","author":"Meuleman","year":"2023","journal-title":"La Presse M\u00e9dicale"},{"issue":"13","key":"10.1016\/j.retram.2025.103512_bib0092","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1073\/pnas.1814797116","article-title":"P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4\/heme-dependent manner","volume":"116","author":"Merle","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2025.103512_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100805","article-title":"Complement in sickle cell disease and targeted therapy: i know one thing, that I know nothing","volume":"48","author":"Tampaki","year":"2021","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.retram.2025.103512_bib0094","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","article-title":"Ischemia-reperfusion injury in sickle cell disease: from basics to therapeutics","volume":"189","author":"Ansari","year":"2019","journal-title":"Am J Pathol"},{"issue":"2\u20133","key":"10.1016\/j.retram.2025.103512_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"issue":"6","key":"10.1016\/j.retram.2025.103512_bib0096","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0097","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1684\/ecn.2013.0328","article-title":"Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition","volume":"24","author":"Keikhaei","year":"2013","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0098","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1186\/s12885-024-12854-x","article-title":"Correlation of TNF-\u03b1 polymorphisms with susceptibility to lung cancer: evidence from a meta-analysis based on 29 studies","volume":"24","author":"HaghighiKian","year":"2024","journal-title":"BMC cancer"},{"issue":"22","key":"10.1016\/j.retram.2025.103512_bib0099","first-page":"2377","article-title":"Targeting novel mechanisms of pain in sickle cell disease","volume":"130","author":"Tran","year":"2017","journal-title":"Blood, J Am Soc Hematology"},{"issue":"20","key":"10.1016\/j.retram.2025.103512_bib0100","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/bloodadvances.2019000193","article-title":"Role of the coagulation system in the pathogenesis of sickle cell disease","volume":"3","author":"Nasimuzzaman","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.retram.2025.103512_bib0101","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103512_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2024.104692","article-title":"Sex-stratified association of variants in the serotonin 1A receptor gene with acute crisis pain among African American patients with sickle cell disease","volume":"142","author":"Sadhu","year":"2025","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0103","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71078-8","article-title":"CXCR4(hi) effector neutrophils in sickle cell anemia: potential role for elevated circulating serotonin (5-HT) in CXCR4(hi) neutrophil polarization","volume":"10","author":"Garcia","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71078-8","article-title":"CXCR4hi effector neutrophils in sickle cell anemia: potential role for elevated circulating serotonin (5-HT) in CXCR4hi neutrophil polarization","volume":"10","author":"Garcia","year":"2020","journal-title":"Sci Rep"},{"issue":"26","key":"10.1016\/j.retram.2025.103512_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar6676","article-title":"Noncanonical inflammasome signaling elicits gasdermin d-dependent neutrophil extracellular traps","volume":"3","author":"Chen","year":"2018","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.retram.2025.103512_bib0106","first-page":"1020","article-title":"Liver-to-lung microembolic NETs promote gasdermin D\u2013dependent inflammatory lung injury in sickle cell disease","volume":"140","author":"Vats","year":"2022","journal-title":"Blood J Am Soc Hematology"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0107","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89761","article-title":"Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli","volume":"2","author":"Bennewitz","year":"2017","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0108","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jth.15581","article-title":"Dietary alpha-linolenic acid reduces platelet activation and collagen-mediated cell adhesion in sickle cell disease mice","volume":"20","author":"Stivala","year":"2022","journal-title":"J Thrombosis Haemostasis"},{"issue":"11 Suppl 1","key":"10.1016\/j.retram.2025.103512_bib0109","article-title":"Assessment of thrombospondin-1 in sickle cell vasoocclusive crisis and its relationship with platelet indices and inflammation","volume":"41","author":"Lawrence","year":"2024","journal-title":"West Afr J Med"},{"issue":"20","key":"10.1016\/j.retram.2025.103512_bib0110","first-page":"1783","article-title":"Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease","volume":"135","author":"Sparkenbaugh","year":"2020","journal-title":"Blood, J Am Soc Hematol"},{"issue":"7","key":"10.1016\/j.retram.2025.103512_bib0111","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jth.13728","article-title":"Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state","volume":"15","author":"Sins","year":"2017","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.retram.2025.103512_bib0112","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00277-019-03776-x","article-title":"Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India","volume":"98","author":"Meher","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.retram.2025.103512_bib0113","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood-2019-122524","article-title":"Soluble P-selectin levels in patients with sickle cell disease reflect platelets' Activation rather than endothelial dysfunction","volume":"134","author":"Voskaridou","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2025.103512_bib0114","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jth.13728","article-title":"Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state","volume":"15","author":"Sins","year":"2017","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.retram.2025.103512_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112178","article-title":"Clinical features, treatment, and outcomes of patients with carfilzomib induced thrombotic microangiopathy","volume":"134","author":"Fang","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0116","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Advances"},{"issue":"11","key":"10.1016\/j.retram.2025.103512_bib0117","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ajh.24498","article-title":"Patterns of opioid use in sickle cell disease","volume":"91","author":"Han","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2025.103512_bib0118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajem.2024.10.028","article-title":"Trends and hospital practice variation for analgesia for children with sickle cell disease with vaso-occlusive pain episodes: an 11-year analysis","volume":"86","author":"Eltorki","year":"2024","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.retram.2025.103512_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.scib.2025.01.016","article-title":"Enhancing panvascular medicine: unveiling the nexus of pan-cardio-oncology and expanding therapeutic frontiers","author":"Hu","year":"2025","journal-title":"Science Bulletin"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/hematology.2021000307","article-title":"Indications for transfusion in the management of sickle cell disease","volume":"2021","author":"Han","year":"2021","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0121","first-page":"725","article-title":"Targeting P-selectin and interleukin-1\u03b2 in mice with sickle cell disease: effects on vaso-occlusion, liver injury and organ iron deposition","volume":"110","author":"Gotardo \u00c9","year":"2025","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0122","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2010-05-285718","article-title":"Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease","volume":"117","author":"Gutsaeva","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0123","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s12012-024-09924-8","article-title":"Potential player of platelet in the pathogenesis of cardiotoxicity: molecular insight and future perspective","volume":"24","author":"Amin","year":"2024","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0124","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/hematology.2020000143","article-title":"Optimizing the management of chronic pain in sickle cell disease","volume":"2020","author":"Osunkwo","year":"2020","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0125","article-title":"Opioid use in patients with sickle cell disease during a vaso-occlusive crisis: a systematic review","volume":"14","author":"Arzoun","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0126","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jcpt.12592","article-title":"Use of anti-inflammatory analgesics in sickle-cell disease","volume":"42","author":"Han","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0127","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood.2020005045","article-title":"Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease","volume":"136","author":"Veluswamy","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2025.103512_bib0128","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","volume":"7","author":"Okomo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jha2.819","article-title":"Mindfulness and yoga therapy for acute pain in sickle cell disease","volume":"5","author":"Dev","year":"2024","journal-title":"EJHaem"},{"key":"10.1016\/j.retram.2025.103512_bib0130","article-title":"Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety","volume":"5","author":"Mayoral","year":"2024","journal-title":"Front Pain Res (Lausanne)"},{"issue":"17","key":"10.1016\/j.retram.2025.103512_bib0131","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2018-08-868893","article-title":"A phase 1\/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease","volume":"133","author":"Howard","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2025.103512_bib0132","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.23725","article-title":"A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease","volume":"89","author":"Reid","year":"2014","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.retram.2025.103512_bib0133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002382","article-title":"Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: a randomized phase 1 study","volume":"14","author":"Molokie","year":"2017","journal-title":"PLoS Med"},{"issue":"20","key":"10.1016\/j.retram.2025.103512_bib0134","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/bloodadvances.2017009613","article-title":"Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease","volume":"1","author":"Field","year":"2017","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171067","article-title":"NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease","volume":"12","author":"Field","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0136","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3945\/ajcn.112.036319","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.retram.2025.103512_bib0137","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pbc.25771","volume":"63","author":"Hoppe","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.retram.2025.103512_bib0138","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of Pain crises in Sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0139","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/hematology.2021000307","article-title":"Indications for transfusion in the management of sickle cell disease","volume":"2021","author":"Han","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"15","key":"10.1016\/j.retram.2025.103512_bib0140","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2174\/1381612823666170220163750","article-title":"Lenticulostriate artery and lenticulostriate-artery neural complex: new concept for intracerebral hemorrhage","volume":"23","author":"Hu","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.retram.2025.103512_bib0141","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40120-021-00279-8","article-title":"Hematoma evacuation via image-guided para-corticospinal tract approach in patients with spontaneous intracerebral hemorrhage","volume":"10","author":"Zhang","year":"2021","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0142","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15537\/smj.2020.1.24698","article-title":"The role of hydroxyurea in decreasing the occurrence of vasso-occulusive crisis in pediatric patients with sickle cell disease at King Saud Medical City in Riyadh, Saudi Arabia","volume":"41","author":"Azmet","year":"2020","journal-title":"Saudi Med J"},{"issue":"10","key":"10.1016\/j.retram.2025.103512_bib0143","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1097\/MS9.0000000000002478","article-title":"CRISPR\/Cas9 in the treatment of sickle cell disease (SCD) and its comparison with traditional treatment approaches: a review","volume":"86","author":"Tariq","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"10.1016\/j.retram.2025.103512_bib0144","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/j.ymthe.2024.07.015","article-title":"Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses","volume":"32","author":"Frati","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.retram.2025.103512_bib0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.omtm.2021.09.010","article-title":"CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease","volume":"23","author":"Demirci","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.retram.2025.103512_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103060","article-title":"CRISPR\/Cas9 gene editing for curing sickle cell disease","volume":"60","author":"Park","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.retram.2025.103512_bib0147","article-title":"Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease","volume":"3","author":"Pal","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1016\/j.retram.2025.103512_bib0148","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1182\/bloodadvances.2022008965","article-title":"The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease","volume":"7","author":"Cronin","year":"2023","journal-title":"Blood Adv"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:14:55Z","timestamp":1757679295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2452318625000212"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103512","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vaso-occlusive pain crisis in sickle cell patients: A focus on pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103512"}}